- Home
- NAOV vs NDRA Comparison
NAOV vs NDRA Comparison
Compare NAOV & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAOV
- NDRA
- Stock Information
- Founded
- NAOV 2003
- NDRA 2007
- Country
- NAOV United States
- NDRA United States
- Employees
- NAOV N/A
- NDRA N/A
- Industry
- NAOV Industrial Specialties
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NAOV Health Care
- NDRA Health Care
- Exchange
- NAOV Nasdaq
- NDRA Nasdaq
- Market Cap
- NAOV 2.4M
- NDRA 2.3M
- IPO Year
- NAOV N/A
- NDRA 2017
- Fundamental
- Price
- NAOV $0.92
- NDRA $6.35
- Analyst Decision
- NAOV
- NDRA Strong Buy
- Analyst Count
- NAOV 0
- NDRA 1
- Target Price
- NAOV N/A
- NDRA $46.00
- AVG Volume (30 Days)
- NAOV 3.0M
- NDRA 5.0M
- Earning Date
- NAOV 08-13-2025
- NDRA 08-13-2025
- Dividend Yield
- NAOV N/A
- NDRA N/A
- EPS Growth
- NAOV N/A
- NDRA N/A
- EPS
- NAOV N/A
- NDRA N/A
- Revenue
- NAOV $2,662,000.00
- NDRA N/A
- Revenue This Year
- NAOV N/A
- NDRA N/A
- Revenue Next Year
- NAOV N/A
- NDRA N/A
- P/E Ratio
- NAOV N/A
- NDRA N/A
- Revenue Growth
- NAOV N/A
- NDRA N/A
- 52 Week Low
- NAOV $0.67
- NDRA $2.90
- 52 Week High
- NAOV $16.25
- NDRA $168.00
- Technical
- Relative Strength Index (RSI)
- NAOV 40.36
- NDRA 54.22
- Support Level
- NAOV $0.89
- NDRA $6.18
- Resistance Level
- NAOV $1.08
- NDRA $7.34
- Average True Range (ATR)
- NAOV 0.07
- NDRA 0.81
- MACD
- NAOV 0.03
- NDRA -0.18
- Stochastic Oscillator
- NAOV 52.29
- NDRA 5.12
About NAOV NanoVibronix Inc.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients, through distributor agreements.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.